Liana Moussatos Joins A Slew of Analysts That Are Gaining More Confidence in Xoma
XOMA Corporation (NASDAQ: XOMA) announced several corporate actions to further streamline its operations to focus on XOMA 358 clinical development, monetize non-core assets, …